Report Detail

Request for Sample of this report

Pharma & Healthcare Global Terbinafine (Lamisil) Sales Market Report 2021

  • RnM3940666
    • |
  • 21 June, 2021
    • |
  • Global
    • |
  • 143 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

The global Terbinafine (Lamisil) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Terbinafine (Lamisil) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Oral
External Use

Segment by Application
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other

The Terbinafine (Lamisil) market is analysed and market size information is provided by regions (countries). Segment by Application, the Terbinafine (Lamisil) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical


1 Terbinafine (Lamisil) Market Overview

  • 1.1 Terbinafine (Lamisil) Product Scope
  • 1.2 Terbinafine (Lamisil) Segment by Type
    • 1.2.1 Global Terbinafine (Lamisil) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Oral
    • 1.2.3 External Use
  • 1.3 Terbinafine (Lamisil) Segment by Application
    • 1.3.1 Global Terbinafine (Lamisil) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Fungal Infection Of The Skin And Mucous Membrane
    • 1.3.3 Onychomycosis
    • 1.3.4 Bronchial Asthma
    • 1.3.5 Gynecological Anti-Infection Preparation
    • 1.3.6 Other
  • 1.4 Terbinafine (Lamisil) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Terbinafine (Lamisil) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Terbinafine (Lamisil) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Terbinafine (Lamisil) Price Trends (2016-2027)

2 Terbinafine (Lamisil) Estimates and Forecasts by Region

  • 2.1 Global Terbinafine (Lamisil) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Terbinafine (Lamisil) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Terbinafine (Lamisil) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Terbinafine (Lamisil) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Terbinafine (Lamisil) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.3 China Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Terbinafine (Lamisil) Estimates and Projections (2016-2027)
    • 2.4.6 India Terbinafine (Lamisil) Estimates and Projections (2016-2027)

3 Global Terbinafine (Lamisil) Competition Landscape by Players

  • 3.1 Global Top Terbinafine (Lamisil) Players by Sales (2016-2021)
  • 3.2 Global Top Terbinafine (Lamisil) Players by Revenue (2016-2021)
  • 3.3 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Terbinafine (Lamisil) as of 2020)
  • 3.4 Global Terbinafine (Lamisil) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Terbinafine (Lamisil) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Terbinafine (Lamisil) Market Size by Type

  • 4.1 Global Terbinafine (Lamisil) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Terbinafine (Lamisil) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Terbinafine (Lamisil) Price by Type (2016-2021)
  • 4.2 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Terbinafine (Lamisil) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Terbinafine (Lamisil) Price Forecast by Type (2022-2027)

5 Global Terbinafine (Lamisil) Market Size by Application

  • 5.1 Global Terbinafine (Lamisil) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Terbinafine (Lamisil) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Terbinafine (Lamisil) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Terbinafine (Lamisil) Price by Application (2016-2021)
  • 5.2 Global Terbinafine (Lamisil) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Terbinafine (Lamisil) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Terbinafine (Lamisil) Price Forecast by Application (2022-2027)

6 North America Terbinafine (Lamisil) Market Facts & Figures

  • 6.1 North America Terbinafine (Lamisil) Sales by Company
    • 6.1.1 North America Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 6.1.2 North America Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 6.2 North America Terbinafine (Lamisil) Sales Breakdown by Type
    • 6.2.1 North America Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Terbinafine (Lamisil) Sales Breakdown by Application
    • 6.3.1 North America Terbinafine (Lamisil) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Terbinafine (Lamisil) Sales Breakdown by Application (2022-2027)

7 Europe Terbinafine (Lamisil) Market Facts & Figures

  • 7.1 Europe Terbinafine (Lamisil) Sales by Company
    • 7.1.1 Europe Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 7.1.2 Europe Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 7.2 Europe Terbinafine (Lamisil) Sales Breakdown by Type
    • 7.2.1 Europe Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Terbinafine (Lamisil) Sales Breakdown by Application
    • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Terbinafine (Lamisil) Market Facts & Figures

  • 8.1 China Terbinafine (Lamisil) Sales by Company
    • 8.1.1 China Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 8.1.2 China Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 8.2 China Terbinafine (Lamisil) Sales Breakdown by Type
    • 8.2.1 China Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 8.3 China Terbinafine (Lamisil) Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Terbinafine (Lamisil) Market Facts & Figures

  • 9.1 Japan Terbinafine (Lamisil) Sales by Company
    • 9.1.1 Japan Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 9.1.2 Japan Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 9.2 Japan Terbinafine (Lamisil) Sales Breakdown by Type
    • 9.2.1 Japan Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Terbinafine (Lamisil) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Terbinafine (Lamisil) Market Facts & Figures

  • 10.1 Southeast Asia Terbinafine (Lamisil) Sales by Company
    • 10.1.1 Southeast Asia Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Terbinafine (Lamisil) Sales Breakdown by Application
    • 10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Terbinafine (Lamisil) Market Facts & Figures

  • 11.1 India Terbinafine (Lamisil) Sales by Company
    • 11.1.1 India Terbinafine (Lamisil) Sales by Company (2016-2021)
    • 11.1.2 India Terbinafine (Lamisil) Revenue by Company (2016-2021)
  • 11.2 India Terbinafine (Lamisil) Sales Breakdown by Type
    • 11.2.1 India Terbinafine (Lamisil) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Terbinafine (Lamisil) Sales Breakdown by Type (2022-2027)
  • 11.3 India Terbinafine (Lamisil) Sales Breakdown by Application
    • 11.3.1 India Terbinafine (Lamisil) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Terbinafine (Lamisil) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Terbinafine (Lamisil) Business

  • 12.1 Perrigo
    • 12.1.1 Perrigo Corporation Information
    • 12.1.2 Perrigo Business Overview
    • 12.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Perrigo Terbinafine (Lamisil) Products Offered
    • 12.1.5 Perrigo Recent Development
  • 12.2 Novartis Pharmaceuticals Corporation
    • 12.2.1 Novartis Pharmaceuticals Corporation Corporation Information
    • 12.2.2 Novartis Pharmaceuticals Corporation Business Overview
    • 12.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Products Offered
    • 12.2.5 Novartis Pharmaceuticals Corporation Recent Development
  • 12.3 Gokul Pharma
    • 12.3.1 Gokul Pharma Corporation Information
    • 12.3.2 Gokul Pharma Business Overview
    • 12.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Gokul Pharma Terbinafine (Lamisil) Products Offered
    • 12.3.5 Gokul Pharma Recent Development
  • 12.4 TEVA
    • 12.4.1 TEVA Corporation Information
    • 12.4.2 TEVA Business Overview
    • 12.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 TEVA Terbinafine (Lamisil) Products Offered
    • 12.4.5 TEVA Recent Development
  • 12.5 Mylan Pharmaceuticals
    • 12.5.1 Mylan Pharmaceuticals Corporation Information
    • 12.5.2 Mylan Pharmaceuticals Business Overview
    • 12.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.5.5 Mylan Pharmaceuticals Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Corporation Information
    • 12.6.2 Pfizer Business Overview
    • 12.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Pfizer Terbinafine (Lamisil) Products Offered
    • 12.6.5 Pfizer Recent Development
  • 12.7 Sivem Pharmaceuticals
    • 12.7.1 Sivem Pharmaceuticals Corporation Information
    • 12.7.2 Sivem Pharmaceuticals Business Overview
    • 12.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.7.5 Sivem Pharmaceuticals Recent Development
  • 12.8 Apotex Corporation
    • 12.8.1 Apotex Corporation Corporation Information
    • 12.8.2 Apotex Corporation Business Overview
    • 12.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Apotex Corporation Terbinafine (Lamisil) Products Offered
    • 12.8.5 Apotex Corporation Recent Development
  • 12.9 Auro Pharma Inc
    • 12.9.1 Auro Pharma Inc Corporation Information
    • 12.9.2 Auro Pharma Inc Business Overview
    • 12.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Auro Pharma Inc Terbinafine (Lamisil) Products Offered
    • 12.9.5 Auro Pharma Inc Recent Development
  • 12.10 PLIVA
    • 12.10.1 PLIVA Corporation Information
    • 12.10.2 PLIVA Business Overview
    • 12.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 PLIVA Terbinafine (Lamisil) Products Offered
    • 12.10.5 PLIVA Recent Development
  • 12.11 Jamp Pharma Corporation
    • 12.11.1 Jamp Pharma Corporation Corporation Information
    • 12.11.2 Jamp Pharma Corporation Business Overview
    • 12.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Products Offered
    • 12.11.5 Jamp Pharma Corporation Recent Development
  • 12.12 Nu Pharm
    • 12.12.1 Nu Pharm Corporation Information
    • 12.12.2 Nu Pharm Business Overview
    • 12.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Nu Pharm Terbinafine (Lamisil) Products Offered
    • 12.12.5 Nu Pharm Recent Development
  • 12.13 Codal Synto
    • 12.13.1 Codal Synto Corporation Information
    • 12.13.2 Codal Synto Business Overview
    • 12.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Codal Synto Terbinafine (Lamisil) Products Offered
    • 12.13.5 Codal Synto Recent Development
  • 12.14 Qd Pharmaceuticals
    • 12.14.1 Qd Pharmaceuticals Corporation Information
    • 12.14.2 Qd Pharmaceuticals Business Overview
    • 12.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Products Offered
    • 12.14.5 Qd Pharmaceuticals Recent Development
  • 12.15 Pharmel Inc
    • 12.15.1 Pharmel Inc Corporation Information
    • 12.15.2 Pharmel Inc Business Overview
    • 12.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Pharmel Inc Terbinafine (Lamisil) Products Offered
    • 12.15.5 Pharmel Inc Recent Development
  • 12.16 Smaart Pharmaceutticals
    • 12.16.1 Smaart Pharmaceutticals Corporation Information
    • 12.16.2 Smaart Pharmaceutticals Business Overview
    • 12.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Products Offered
    • 12.16.5 Smaart Pharmaceutticals Recent Development
  • 12.17 Qilu Pharmaceutical
    • 12.17.1 Qilu Pharmaceutical Corporation Information
    • 12.17.2 Qilu Pharmaceutical Business Overview
    • 12.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Products Offered
    • 12.17.5 Qilu Pharmaceutical Recent Development
  • 12.18 Qingdao Jinfeng Pharmaceutical
    • 12.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
    • 12.18.2 Qingdao Jinfeng Pharmaceutical Business Overview
    • 12.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Products Offered
    • 12.18.5 Qingdao Jinfeng Pharmaceutical Recent Development

13 Terbinafine (Lamisil) Manufacturing Cost Analysis

  • 13.1 Terbinafine (Lamisil) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
  • 13.4 Terbinafine (Lamisil) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Terbinafine (Lamisil) Distributors List
  • 14.3 Terbinafine (Lamisil) Customers

15 Market Dynamics

  • 15.1 Terbinafine (Lamisil) Market Trends
  • 15.2 Terbinafine (Lamisil) Drivers
  • 15.3 Terbinafine (Lamisil) Market Challenges
  • 15.4 Terbinafine (Lamisil) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Terbinafine (Lamisil). Industry analysis & Market Report on Terbinafine (Lamisil) is a syndicated market report, published as Global Terbinafine (Lamisil) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Terbinafine (Lamisil) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,092.00
    		4,638.00
    		6,184.00
    		3,724.00
    		5,586.00
    		7,448.00
    		610,760.00
    		916,140.00
    		1,221,520.00
    		337,600.00
    		506,400.00
    		675,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo